A carregar...
Clinical Challenges with Talimogene Laherparepvec: Cured Lymph Nodes Masquerading as Active Melanoma
Talimogene laherparepvec is a novel, genetically engineered, oncolytic herpes virus approved for local treatment of unresectable cutaneous, subcutaneous, and nodal lesions in patients with melanoma recurrent after initial surgery. It is administered as an intralesional injection. However, if the les...
Na minha lista:
| Publicado no: | Case Rep Oncol Med |
|---|---|
| Main Authors: | , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Hindawi
2019
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6431461/ https://ncbi.nlm.nih.gov/pubmed/30963012 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2019/4683531 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|